162 related articles for article (PubMed ID: 4439867)
1. Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man.
Lintz W; Berger W; Aenishaenslin W; Kutova V; Baerlocher C; Kapp JP; Beckmann R
Eur J Clin Pharmacol; 1974 Oct; 7(6):433-48. PubMed ID: 4439867
[No Abstract] [Full Text] [Related]
2. Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin retard).
Beckmann R; Lintz W; Schmidt-Böthelt E
Eur J Clin Pharmacol; 1971 Sep; 3(4):221-8. PubMed ID: 5151304
[No Abstract] [Full Text] [Related]
3. [Intravenous dimethylbiquanide and the tolbutamide test. Experimental study].
Bellomo A; Beggiato O; Strobbia R
Minerva Med; 1972 Jan; 63(5):291-5. PubMed ID: 5012344
[No Abstract] [Full Text] [Related]
4. [Distribution and excretion of 14c-butylbiguanide in man (author's transl)].
Ritzl F; Feinendegen LE; Lintz W; Tisljar U
Arzneimittelforschung; 1978; 28(7):1184-6. PubMed ID: 582707
[TBL] [Abstract][Full Text] [Related]
5. [Distribution of 1-butyl-biguanide- 14 C in rats and guinea pigs].
Losert W; Kolb KH; Bitterling G
Arzneimittelforschung; 1972 May; 22(5):937-46. PubMed ID: 5068215
[No Abstract] [Full Text] [Related]
6. Oral versus intravenous administration of butylbiguanide: effect on oral glucose tolerance in normal humans.
Berger EG; Moehr P
Eur J Clin Invest; 1976 Jun; 6(3):221-8. PubMed ID: 939245
[TBL] [Abstract][Full Text] [Related]
7. Distribution of n-butylbiguanide-14C hydrochloride in mouse tissues.
Yoh YJ
Jpn J Pharmacol; 1967 Sep; 17(3):439-49. PubMed ID: 5300191
[No Abstract] [Full Text] [Related]
8. [Biguanides in the oral treatment of diabetes mellitus].
Rojas Hidalgo E
Rev Clin Esp; 1968 Jul; 110(1):69-78 contd. PubMed ID: 5735078
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics and metabolism of alpha-acetyldigoxin in man.
Bodem G; Wirth K; Gernand E; Dengler HJ
Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):102-16. PubMed ID: 4846188
[No Abstract] [Full Text] [Related]
10. Distribution and elimination of [14C] in saithe (Pollachius virens L.) after application of a single dose of [14C] polyhexamethylene hydrochloridebiguanide.
Christiansen R; Palmork KH
Bull Environ Contam Toxicol; 1996 Jan; 56(1):121-28. PubMed ID: 9026145
[No Abstract] [Full Text] [Related]
11. [Importance of N-butylbiguanide in the treatment of diabetes of maturity].
Daubresse JC; Luyckx A; Lefebvre P
Rev Med Liege; 1975 Jan; 30(2):41-5. PubMed ID: 1118699
[No Abstract] [Full Text] [Related]
12. [Absorption, distribution and excretion of penicillin V in rats. 2. Compartment studies].
Niedermüller H; Brunner R
Arzneimittelforschung; 1974 Dec; 24(12):1979-86. PubMed ID: 4217630
[No Abstract] [Full Text] [Related]
13. Absorption, distribution and excretion of inorganic tin in rats.
Hiles RA
Toxicol Appl Pharmacol; 1974 Feb; 27(2):366-79. PubMed ID: 4850377
[No Abstract] [Full Text] [Related]
14. First-pass metabolism of cyclosporine A in human intestine: inhibition by diltiazem.
Preuner JG; Lehle K; Eichinger H; Rupprecht L
Transplant Proc; 1998 Sep; 30(6):2545-6. PubMed ID: 9745480
[No Abstract] [Full Text] [Related]
15. The fate of biguanides in man.
Beckmann R
Ann N Y Acad Sci; 1968 Mar; 148(3):820-32. PubMed ID: 5241479
[No Abstract] [Full Text] [Related]
16. [Treatment of diabetes mellitus with long-acting biguanides].
Kliachko VR; Perelygina AA; Mazovetskiĭ AG; Slavina LS
Probl Endokrinol (Mosk); 1976; 22(3):22-6. PubMed ID: 935083
[TBL] [Abstract][Full Text] [Related]
17. [Chemistry, toxicology, pharmacodynamics and mechanism of action of biguanides].
Ezechieli S
Clin Ter; 1970 Aug; 54(4):351-80. PubMed ID: 4992475
[No Abstract] [Full Text] [Related]
18. [Concentration of 14C-1-butylbiguanide in plasma of diabetic patients and its elimination after administration of a new Galenical formulation (author's transl)].
Gutsche H; Blumenbach L; Losert W; Wiemann H
Arzneimittelforschung; 1976; 26(6):1227-9. PubMed ID: 989423
[TBL] [Abstract][Full Text] [Related]
19. [Combined administration of insulin and oral agents].
Tasaka H
Nihon Rinsho; 1973 Jul; 31(7):2286-93. PubMed ID: 4795329
[No Abstract] [Full Text] [Related]
20. [Comparative studies of the effect of N1-n-butylbiguanide hydrochloride (Buformin) and N1-n-butylbiguanide tosylate (Buformin retard)].
Singer P; Thoelke H
Z Gesamte Inn Med; 1973 Aug; 28(16):504-6. PubMed ID: 4767598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
